Dr. Reddys Laboratories Ltd.

The United States Food & Drug Administration (USFDA) has completed a routine GMP inspection at Dr. Reddy's Laboratories’ API manufacturing facility (CTO 1) in Bollaram, Hyderabad. The company has been issued a Form 483 with one observations, which it will address within the stipulated timeline. The inspection was conducted from May 1, 2023 to May 5, 2023. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.